Atom Investors LP Vericel Corp Transaction History

Atom Investors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$23.85 - $31.34 $181,641 - $238,685	7,616 New	7,616 $223,000
Q3 2020 Nov 13, 2020	SELL	$14.68 - $19.12 $294,583 - $383,681	-20,067 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$8.5 - $15.82 $170,569 - $317,459	20,067 New	20,067 $277,000
Q1 2020 May 15, 2020	SELL	$7.25 - $19.22 $557,177 - $1.48 Million	-76,852 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$13.77 - $19.2 $1.91 Million - $2.67 Million	-139,027 Reduced 64.4%	76,852 $1.34 Million
Q3 2019 Nov 14, 2019	BUY	$14.93 - $19.83 $1.41 Million - $1.87 Million	94,109 Added 77.28%	215,879 $3.27 Million
Q2 2019 Aug 14, 2019	BUY	$15.01 - $18.89 $1.83 Million - $2.3 Million	121,770 New	121,770 $2.3 Million

276

48.5M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.67B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.